Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4677

1.

Postmortem urine concentration of N-terminal pro-brain natriuretic peptide in relation to the cause of death.

Takasu S, Matsumoto S, Kanto Y, Kodama S, Iwadate K.

Forensic Sci Int. 2019 Nov 26;306:110079. doi: 10.1016/j.forsciint.2019.110079. [Epub ahead of print]

PMID:
31812084
2.

Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc.

Sourbier C, Ricketts CJ, Liao PJ, Matsumoto S, Wei D, Lang M, Railkar R, Yang Y, Wei MH, Agarwal P, Krishna M, Mitchell JB, Trepel JB, Neckers L, Linehan WM.

Sci Rep. 2019 Dec 5;9(1):18409. doi: 10.1038/s41598-019-55003-2.

3.

Meropenem pharmacokinetics during relapsing peritonitis due to ESBL-producing Enterobacteriaciae in a liver transplant recipient.

Shoji K, Saito J, Oho Y, Matsumoto S, Aoki S, Fukuda A, Sakamoto S, Kasahara M, Capparelli E, Miyairi I.

Clin Case Rep. 2019 Sep 30;7(11):2169-2173. doi: 10.1002/ccr3.2398. eCollection 2019 Nov.

4.

Systemic Psoriasiform Dermatitis Appeared after the Administration of Pembrolizumab.

Suzuki M, Matsumoto S, Takeda Y, Sugiyama H.

Intern Med. 2019 Nov 29. doi: 10.2169/internalmedicine.3694-19. [Epub ahead of print] No abstract available.

5.

Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic colorectal cancer surgery.

Kamonvarapitak T, Matsuda A, Matsumoto S, Jamjittrong S, Sakurazawa N, Kawano Y, Yamada T, Suzuki H, Miyashita M, Yoshida H.

Int J Clin Oncol. 2019 Nov 28. doi: 10.1007/s10147-019-01583-y. [Epub ahead of print]

PMID:
31781993
7.

[A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in an elderly woman].

Matsumoto S, Nishihara K, Hasegawa M, Satake S, Endo H, Arai H.

Nihon Ronen Igakkai Zasshi. 2019;56(4):525-531. doi: 10.3143/geriatrics.56.525. Japanese.

8.

Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairment.

Kumagai Y, Sakaki M, Furihata K, Ito T, Inoue K, Yoshida T, Matsumoto S, Furuno K, Hagino A.

Clin Exp Nephrol. 2019 Nov 23. doi: 10.1007/s10157-019-01816-4. [Epub ahead of print]

PMID:
31760530
9.

Regulation of the KCNJ5 gene by SF-1 in the adrenal cortex: Complete genomic organization and promoter function.

Nishikido A, Okamura T, Nakajima Y, Ishida E, Miyamoto T, Toki AK, Matsumoto S, Yoshino S, Horiguchi K, Saito T, Yamada E, Ozawa A, Shimoda Y, Oyama T, Yamada M.

Mol Cell Endocrinol. 2019 Nov 18;501:110657. doi: 10.1016/j.mce.2019.110657. [Epub ahead of print]

PMID:
31751625
10.

Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.

Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Thromb Thrombolysis. 2019 Nov 19. doi: 10.1007/s11239-019-01979-7. [Epub ahead of print]

PMID:
31745858
11.

A Visual Task Management Application for Acute Ischemic Stroke Care.

Matsumoto S, Koyama H, Nakahara I, Ishii A, Hatano T, Ohta T, Tanaka K, Ando M, Chihara H, Takita W, Tokunaga K, Hashikawa T, Funakoshi Y, Kamata T, Higashi E, Watanabe S, Kondo D, Tsujimoto A, Furuta K, Ishihara T, Hashimoto T, Koge J, Sonoda K, Torii T, Nakagaki H, Yamasaki R, Nagata I, Kira JI.

Front Neurol. 2019 Oct 30;10:1118. doi: 10.3389/fneur.2019.01118. eCollection 2019.

12.

Long-term survival and renal dysfunction in a patient with recurrent colorectal cancer treated with Bevacizumab.

Kataoka S, Nishikawa Y, Funakoshi T, Horimatsu T, Kondo N, Matsubara T, Yanagita M, Matsumoto S, Muto M.

Clin J Gastroenterol. 2019 Nov 9. doi: 10.1007/s12328-019-01060-z. [Epub ahead of print]

PMID:
31707696
13.

The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy.

Kuroda A, Matsumoto S, Fukuda A, Nakamichi T, Nakamura A, Hashimoto M, Takuwa T, Kondo N, Tsujimura T, Nakano T, Hasegawa S.

Anticancer Res. 2019 Nov;39(11):6241-6247. doi: 10.21873/anticanres.13833.

PMID:
31704853
14.

Signet ring cell carcinoma and poorly differentiated adenocarcinoma in a gastric hyperplastic polyp with lymphatic invasion: A case report.

Takahashi K, Saito S, Kaneko Y, Matsumoto S, Yamaguchi H, Kitayama J, Hosoya Y, Kawata H, Lefor AK, Sata N.

Int J Surg Case Rep. 2019;64:180-183. doi: 10.1016/j.ijscr.2019.10.019. Epub 2019 Oct 17.

15.

High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice.

Takigawa M, Yatsu T, Takino Y, Matsumoto S, Kitano T, Lee J, Arai T, Tanaka H, Ishii T, Mori Y, Ishigami A.

J Nutr Sci Vitaminol (Tokyo). 2019;65(5):399-404. doi: 10.3177/jnsv.65.399.

16.

Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.

Yamazaki K, Matsumoto S, Imamura CK, Yamagiwa C, Shimizu A, Yoshino T.

Jpn J Clin Oncol. 2019 Oct 28. pii: hyz149. doi: 10.1093/jjco/hyz149. [Epub ahead of print]

PMID:
31665356
17.

The VAC regimen for adult rhabdomyosarcoma: Differences between adolescent/young adult and older patients.

Nakano K, Ae K, Matsumoto S, Takahashi S.

Asia Pac J Clin Oncol. 2019 Oct 28. doi: 10.1111/ajco.13279. [Epub ahead of print]

PMID:
31657883
18.

Recent developments in undergraduate education in psychiatry in Japan.

Akiyama T, Bernick P, Matsumoto S, Tagawa A.

Int Rev Psychiatry. 2019 Oct 28:1-6. doi: 10.1080/09540261.2019.1676205. [Epub ahead of print]

PMID:
31656112
19.

Optimizing in-hospital triage for large vessel occlusion using a novel clinical scale (GAI2AA).

Ohta T, Nakahara I, Matsumoto S, Kondo D, Watanabe S, Okada K, Fukuda M, Masahira N, Tsuno T, Matsuoka T, Takemura M, Fukuda H, Fukui N, Ueba T.

Neurology. 2019 Nov 26;93(22):e1997-e2006. doi: 10.1212/WNL.0000000000008550. Epub 2019 Oct 24.

PMID:
31649112
20.

Facile Synthesis of Poly(Glycidyl Ether)s with Ionic Pendant Groups by Thiol-Ene Reactions.

Hatakeyama-Sato K, Kimura S, Matsumoto S, Oyaizu K.

Macromol Rapid Commun. 2019 Oct 21:e1900399. doi: 10.1002/marc.201900399. [Epub ahead of print]

PMID:
31631438
21.

[Long-Term Complete Response in an Unresectable Advanced Gastric Cancer Patient Treated with Low-Dose S-1].

Ando F, Matsuda A, Suzuki H, Matsumoto S, Sakurazawa N, Kawano Y, Yamahatsu K, Miyashita M, Yoshida H.

Gan To Kagaku Ryoho. 2019 Oct;46(10):1573-1575. Japanese.

PMID:
31631142
22.

Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.

Naito T, Udagawa H, Umemura S, Sakai T, Zenke Y, Kirita K, Matsumoto S, Yoh K, Niho S, Tsuboi M, Ishii G, Goto K.

Lung Cancer. 2019 Dec;138:35-42. doi: 10.1016/j.lungcan.2019.10.009. Epub 2019 Oct 13.

PMID:
31630044
23.

Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing.

Yamamoto Y, Kanai M, Kou T, Sugiyama A, Nakamura E, Miyake H, Yamada T, Nishigaki M, Kondo T, Murakami H, Torishima M, Matsumoto S, Kosugi S, Muto M.

J Hum Genet. 2019 Oct 18. doi: 10.1038/s10038-019-0681-6. [Epub ahead of print]

PMID:
31628423
24.

Relationship between Vision-Related Quality of Life and Central 10° of the Binocular Integrated Visual Field in Advanced Glaucoma.

Yamazaki Y, Sugisaki K, Araie M, Murata H, Kanamori A, Inoue T, Ishikawa S, Yoshikawa K, Maeda H, Yamada Y, Negi A, Inatani M, Tanihara H, Okinami S, Mizuki K, Mishima K, Uchida K, Matsumoto S.

Sci Rep. 2019 Oct 18;9(1):14990. doi: 10.1038/s41598-019-50677-0.

25.

Clostridium botulinum infection in an exclusively breast-fed infant.

Matsumoto S, Saito T, Kobayashi Y, Ito S, Kaburagi Y.

Pediatr Int. 2019 Oct;61(10):1050-1051. doi: 10.1111/ped.13986. Epub 2019 Oct 14. No abstract available.

PMID:
31612604
26.

The Effect of S-Adenosylmethionine Treatment on Neurobehavioral Phenotypes in Lesch-Nyhan Disease: A Case Report.

Momosaki K, Kido J, Matsumoto S, Taniguchi A, Akiyama T, Sawada T, Ozasa S, Nakamura K.

Case Rep Neurol. 2019 Sep 19;11(3):256-264. doi: 10.1159/000502568. eCollection 2019 Sep-Dec.

27.

Rescue from Stx2-Producing E. coli-Associated Encephalopathy by Intravenous Injection of Muse Cells in NOD-SCID Mice.

Ozuru R, Wakao S, Tsuji T, Ohara N, Matsuba T, Amuran MY, Isobe J, Iino M, Nishida N, Matsumoto S, Iwadate K, Konishi N, Yasuda K, Tashiro K, Hida M, Yadoiwa A, Kato S, Yamashita E, Matsumoto S, Kurozawa Y, Dezawa M, Fujii J.

Mol Ther. 2019 Oct 1. pii: S1525-0016(19)30452-6. doi: 10.1016/j.ymthe.2019.09.023. [Epub ahead of print]

28.

Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment.

Matsumoto S, Yonai S, Bolch WE.

Med Phys. 2019 Dec;46(12):5824-5832. doi: 10.1002/mp.13864. Epub 2019 Oct 29.

PMID:
31603561
29.

A new DNA marker CafLess-TCS1 for selection of caffeine-less tea plants.

Ogino A, Taniguchi F, Yoshida K, Matsumoto S, Fukuoka H, Nesumi A.

Breed Sci. 2019 Sep;69(3):393-400. doi: 10.1270/jsbbs.18161. Epub 2019 Jun 29.

30.

Morphological difference between pleural mesothelioma cells in effusion smears with either BAP1 loss or 9p21 homozygous deletion and reactive mesothelial cells without the gene alterations.

Matsumoto S, Hamasaki M, Kinoshita Y, Kamei T, Kawahara K, Nabeshima K.

Pathol Int. 2019 Nov;69(11):637-645. doi: 10.1111/pin.12862. Epub 2019 Oct 3.

PMID:
31580004
31.

Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes.

Ito H, Matsumoto S, Izutsu T, Kusano E, Nishio S, Antoku S, Yamasaki T, Mori T, Togane M, Ando S, Tsugami E.

Diabetes Metab Syndr Obes. 2019 Sep 9;12:1783-1794. doi: 10.2147/DMSO.S221655. eCollection 2019.

32.

Population pharmacokinetic and exposure-response analyses of guanfacine in Japanese pediatric ADHD patients.

Tsuda Y, Matsuo Y, Matsumoto S, Wajima T.

Drug Metab Pharmacokinet. 2019 Dec;34(6):365-371. doi: 10.1016/j.dmpk.2019.07.001. Epub 2019 Jul 4.

33.

Survival outcomes after sentinel node navigation surgery for early gastric cancer.

Isozaki H, Matsumoto S, Murakami S.

Ann Gastroenterol Surg. 2019 Jul 25;3(5):552-560. doi: 10.1002/ags3.12280. eCollection 2019 Sep.

34.

Specific distribution of expression and enzymatic activity of cholesterol biosynthetic enzyme DHCR24 orthologs in the phytophagous insect.

Fujimori H, Zhou YJ, Fukumura K, Matsumoto S, Tukamoto Y, Nagata S.

Biosci Biotechnol Biochem. 2020 Jan;84(1):126-133. doi: 10.1080/09168451.2019.1667221. Epub 2019 Sep 20.

PMID:
31538545
35.

Case of mesenchymal tumor with the PPP6R3-USP6 fusion, possible nodular fasciitis with malignant transformation.

Teramura Y, Yamazaki Y, Tanaka M, Sugiura Y, Takazawa Y, Takeuchi K, Nakayama T, Kaneko T, Musha Y, Funauchi Y, Ae K, Matsumoto S, Nakamura T.

Pathol Int. 2019 Sep 19. doi: 10.1111/pin.12851. [Epub ahead of print]

PMID:
31538390
36.

Clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes: A retrospective study.

Tamaki S, Kanazawa A, Sato J, Tamura Y, Asahara T, Takahashi T, Matsumoto S, Yamashiro Y, Watada H.

PLoS One. 2019 Sep 19;14(9):e0222598. doi: 10.1371/journal.pone.0222598. eCollection 2019.

37.

Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.

Nakade H, Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Miyao S, Sho M.

Int J Clin Oncol. 2019 Sep 18. doi: 10.1007/s10147-019-01547-2. [Epub ahead of print]

PMID:
31535245
38.

Fluorescence Properties and Exciplex Formation of Emissive Naphthyridine Derivatives: Application as Sensors for Amines.

Hirota J, Usui K, Fuchi Y, Sakuma M, Matsumoto S, Hagihara R, Karasawa S.

Chemistry. 2019 Nov 22;25(65):14943-14952. doi: 10.1002/chem.201903643. Epub 2019 Oct 28.

PMID:
31512286
39.

Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.

Ishikawa Y, Nakayama K, Morimoto M, Mizutani A, Nakayama A, Toyoshima K, Hayashi A, Takagi S, Dairiki R, Miyashita H, Matsumoto S, Gamo K, Nomura T, Nakamura K.

Oncogenesis. 2019 Sep 11;8(9):51. doi: 10.1038/s41389-019-0160-0.

40.

Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.

Ota T, Kirita K, Matsuzawa R, Udagawa H, Matsumoto S, Yoh K, Niho S, Ishii G, Goto K.

J Cancer Res Clin Oncol. 2019 Oct;145(10):2495-2506. doi: 10.1007/s00432-019-03012-z. Epub 2019 Sep 7.

PMID:
31494736
41.

A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.

Su W, Matsumoto S, Banine F, Srivastava T, Dean J, Foster S, Pham P, Hammond B, Peters A, Girish KS, Rangappa KS, Basappa, Jose J, Hennebold JD, Murphy MJ, Bennett-Toomey J, Back SA, Sherman LS.

Glia. 2020 Feb;68(2):263-279. doi: 10.1002/glia.23715. Epub 2019 Sep 6.

PMID:
31490574
42.

Acute changes in cortical activation during active ankle movement after whole-body vibration for spasticity in hemiplegic legs of stroke patients: a functional near-infrared spectroscopy study.

Miyara K, Kawamura K, Matsumoto S, Ohwatashi A, Itashiki Y, Uema T, Noma T, Ikeda K, Shimodozono M.

Top Stroke Rehabil. 2019 Sep 4:1-8. doi: 10.1080/10749357.2019.1659639. [Epub ahead of print]

PMID:
31483746
43.

Rhabdomyolysis in organic acidemia patients manifesting with metabolic decompensation.

Kido J, Matsumoto S, Sawada T, Endo F, Nakamura K.

Hemodial Int. 2019 Oct;23(4):E115-E119. doi: 10.1111/hdi.12778. Epub 2019 Sep 2.

PMID:
31476111
44.

Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma.

Kawaguchi K, Nakano K, Urasaki T, Fukuda N, Taira S, Ono M, Tomomatsu J, Nishizawa M, Ae K, Matsumoto S, Takahashi S.

In Vivo. 2019 Sep-Oct;33(5):1609-1614. doi: 10.21873/invivo.11644.

45.

Influence of alpha-adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Matsumoto S, Kasamo S, Hashizume K.

Low Urin Tract Symptoms. 2019 Aug 29. doi: 10.1111/luts.12289. [Epub ahead of print]

PMID:
31464384
46.

GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.

Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, Obika S, Takehara T, Morii E, Okuyama H, Kikuchi A.

Nat Commun. 2019 Aug 28;10(1):3882. doi: 10.1038/s41467-019-11533-x.

47.

Study of Commodity VR for Computational Material Sciences.

Hagita K, Matsumoto S, Ota K.

ACS Omega. 2019 Feb 22;4(2):3990-3999. doi: 10.1021/acsomega.8b03483. eCollection 2019 Feb 28.

48.

Selective Formation of Internal Olefinic Trimer of α-Methylstyrenes with HI Gas and Ketones.

Matsumoto S, Oseki T, Akazome M, Otani Y.

ACS Omega. 2018 Dec 20;3(12):17928-17935. doi: 10.1021/acsomega.8b03168. eCollection 2018 Dec 31.

49.

Longitudinal Stent Elongation of a Tapered Lesion during Percutaneous Coronary Intervention: A Case Report.

Matsumoto S, Sakakibara M, Nishikawa N.

Int J Angiol. 2019 Sep;28(3):200-201. doi: 10.1055/s-0038-1629919. Epub 2018 Feb 20.

PMID:
31452588
50.

Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors.

Miyatani H, Mashima H, Sekine M, Matsumoto S.

Ther Adv Gastrointest Endosc. 2019 Aug 12;12:2631774519867184. doi: 10.1177/2631774519867184. eCollection 2019 Jan-Dec.

Supplemental Content

Loading ...
Support Center